BioCardia Signs Agreement With Leading Japanese Pharmaceutical Company for Catheter Biotherapeutic Delivery Product Candidates

    NEXT STORY
    With Monaghan Medical, Safe Nebulizer Therapy is Possible
    PREV STORY
    Black Diamond Therapeutics to Present at Upcoming Investor Conferences
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Ritter Pharmaceuticals, Inc.’s Board Approves 1-for-10 Reverse Stock Split

    Los Angeles, California, March 01, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ...

    author_avatar
    NASDAQ Market News

    Medivir focuses exclusively on oncology and reorganizes to significantly reduce the cost structure

    Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces a reorganization of the ...

    author_avatar
    NASDAQ Market News

    ABLYNX PRICES $200 MILLION INITIAL PUBLIC OFFERING IN THE UNITED STATES

    REGULATED INFORMATION - INSIDE INFORMATION25 October 2017 - 2 am CEST GHENT, Belgium, 25 ...

    author_avatar
    NASDAQ Market News